Comparison Overview

Teva Pharmaceuticals

VS

Merck KGaA, Darmstadt, Germany

Teva Pharmaceuticals

124 Dvora hanevi'a, Tel-Aviv, undefined, 6944020, IL
Last Update: 2025-12-17
Between 800 and 849

At Teva, we're proud to be a different kind of global pharmaceutical leader, one that operates across the full spectrum of innovation to reliably deliver medicines to patients worldwide. For over 120 years, our commitment to bettering health has never wavered. Every day, we challenge ourselves to push the boundaries of science, discover life-changing treatments, and deliver quality medicines. If patients have a need, we’re already working to address it. Because here, we are all in for better health. Learn more at www.tevapharm.com. Please note that adverse effects for any of our products should be reported to: [email protected] Product-specific questions should be directed to Teva or Teva Group subsidiaries in your country. Contact details and Teva's Pharmacovigilance Privacy Policy may be found here: http://www.tevapharm.com/contact_us/

NAICS: 3254
NAICS Definition: Pharmaceutical and Medicine Manufacturing
Employees: 29,653
Subsidiaries: 5
12-month incidents
0
Known data breaches
0
Attack type number
0

Merck KGaA, Darmstadt, Germany

Frankfurter Str. 250, Darmstadt, DE, 64293
Last Update: 2025-12-17
Between 800 and 849

We are Merck KGaA, Darmstadt, Germany and its global affiliates. We are a leading global science and technology company headquartered in Germany. We are curious explorers, courageous pioneers, and ingenious inventors. Our colleagues across the globe love innovating with science and technology to enrich people’s lives with our solutions in Life Science, Healthcare, and Electronics. Together, we dream big and are passionate about caring for our rich mix of people, customers, patients, and the planet. We believe in the positive power of science and technology. It has determined our actions since 1668 and inspires us to continue researching for a future worth living. As a family-owned company with over 350 years of experience, we stand for sustainability, responsibility, and innovative strength. We take pride in being a diverse and inclusive company that values and fosters the talents and abilities of our employees. That's why we are always looking for curious minds that see themselves imagining the unimaginable with us. Privacy Statement: https://www.emdgroup.com/en/privacy-statement.html

NAICS: 3254
NAICS Definition: Pharmaceutical and Medicine Manufacturing
Employees: 12,264
Subsidiaries: 3
12-month incidents
0
Known data breaches
0
Attack type number
0

Compliance Badges Comparison

Security & Compliance Standards Overview

https://images.rankiteo.com/companyimages/teva-pharmaceuticals.jpeg
Teva Pharmaceuticals
ISO 27001
ISO 27001 certification not verified
Not verified
SOC2 Type 1
SOC2 Type 1 certification not verified
Not verified
SOC2 Type 2
SOC2 Type 2 certification not verified
Not verified
GDPR
GDPR certification not verified
Not verified
PCI DSS
PCI DSS certification not verified
Not verified
HIPAA
HIPAA certification not verified
Not verified
https://images.rankiteo.com/companyimages/emd-affiliates-of-merck-kgaa-darmstadt-germany.jpeg
Merck KGaA, Darmstadt, Germany
ISO 27001
ISO 27001 certification not verified
Not verified
SOC2 Type 1
SOC2 Type 1 certification not verified
Not verified
SOC2 Type 2
SOC2 Type 2 certification not verified
Not verified
GDPR
GDPR certification not verified
Not verified
PCI DSS
PCI DSS certification not verified
Not verified
HIPAA
HIPAA certification not verified
Not verified
Compliance Summary
Teva Pharmaceuticals
100%
Compliance Rate
0/4 Standards Verified
Merck KGaA, Darmstadt, Germany
0%
Compliance Rate
0/4 Standards Verified

Benchmark & Cyber Underwriting Signals

Incidents vs Pharmaceutical Manufacturing Industry Average (This Year)

No incidents recorded for Teva Pharmaceuticals in 2025.

Incidents vs Pharmaceutical Manufacturing Industry Average (This Year)

No incidents recorded for Merck KGaA, Darmstadt, Germany in 2025.

Incident History — Teva Pharmaceuticals (X = Date, Y = Severity)

Teva Pharmaceuticals cyber incidents detection timeline including parent company and subsidiaries

Incident History — Merck KGaA, Darmstadt, Germany (X = Date, Y = Severity)

Merck KGaA, Darmstadt, Germany cyber incidents detection timeline including parent company and subsidiaries

Notable Incidents

Last 3 Security & Risk Events by Company

https://images.rankiteo.com/companyimages/teva-pharmaceuticals.jpeg
Teva Pharmaceuticals
Incidents

No Incident

https://images.rankiteo.com/companyimages/emd-affiliates-of-merck-kgaa-darmstadt-germany.jpeg
Merck KGaA, Darmstadt, Germany
Incidents

No Incident

FAQ

Merck KGaA, Darmstadt, Germany company demonstrates a stronger AI Cybersecurity Score compared to Teva Pharmaceuticals company, reflecting its advanced cybersecurity posture governance and monitoring frameworks.

Historically, Merck KGaA, Darmstadt, Germany company has disclosed a higher number of cyber incidents compared to Teva Pharmaceuticals company.

In the current year, Merck KGaA, Darmstadt, Germany company and Teva Pharmaceuticals company have not reported any cyber incidents.

Neither Merck KGaA, Darmstadt, Germany company nor Teva Pharmaceuticals company has reported experiencing a ransomware attack publicly.

Neither Merck KGaA, Darmstadt, Germany company nor Teva Pharmaceuticals company has reported experiencing a data breach publicly.

Neither Merck KGaA, Darmstadt, Germany company nor Teva Pharmaceuticals company has reported experiencing targeted cyberattacks publicly.

Neither Teva Pharmaceuticals company nor Merck KGaA, Darmstadt, Germany company has reported experiencing or disclosing vulnerabilities publicly.

Neither Teva Pharmaceuticals nor Merck KGaA, Darmstadt, Germany holds any compliance certifications.

Neither company holds any compliance certifications.

Teva Pharmaceuticals company has more subsidiaries worldwide compared to Merck KGaA, Darmstadt, Germany company.

Teva Pharmaceuticals company employs more people globally than Merck KGaA, Darmstadt, Germany company, reflecting its scale as a Pharmaceutical Manufacturing.

Neither Teva Pharmaceuticals nor Merck KGaA, Darmstadt, Germany holds SOC 2 Type 1 certification.

Neither Teva Pharmaceuticals nor Merck KGaA, Darmstadt, Germany holds SOC 2 Type 2 certification.

Neither Teva Pharmaceuticals nor Merck KGaA, Darmstadt, Germany holds ISO 27001 certification.

Neither Teva Pharmaceuticals nor Merck KGaA, Darmstadt, Germany holds PCI DSS certification.

Neither Teva Pharmaceuticals nor Merck KGaA, Darmstadt, Germany holds HIPAA certification.

Neither Teva Pharmaceuticals nor Merck KGaA, Darmstadt, Germany holds GDPR certification.

Latest Global CVEs (Not Company-Specific)

Description

Hitachi Vantara Pentaho Data Integration and Analytics Community Dashboard Framework prior to versions 10.2.0.4, including 9.3.0.x and 8.3.x display the full server stack trace when encountering an error within the GetCdfResource servlet.

Risk Information
cvss3
Base: 5.3
Severity: LOW
CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:L/I:N/A:N
Description

Pentaho Data Integration and Analytics Community Dashboard Editor plugin versions before 10.2.0.4, including 9.3.0.x and 8.3.x, deserialize untrusted JSON data without constraining the parser to approved classes and methods.

Risk Information
cvss3
Base: 8.8
Severity: LOW
CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:H/I:H/A:H
Description

A security flaw has been discovered in CTCMS Content Management System up to 2.1.2. The impacted element is an unknown function in the library /ctcms/libs/Ct_Config.php of the component Backend System Configuration Module. The manipulation of the argument Cj_Add/Cj_Edit results in code injection. The attack can be executed remotely. The exploit has been released to the public and may be exploited.

Risk Information
cvss2
Base: 5.8
Severity: LOW
AV:N/AC:L/Au:M/C:P/I:P/A:P
cvss3
Base: 4.7
Severity: LOW
CVSS:3.1/AV:N/AC:L/PR:H/UI:N/S:U/C:L/I:L/A:L
cvss4
Base: 5.1
Severity: LOW
CVSS:4.0/AV:N/AC:L/AT:N/PR:H/UI:N/VC:L/VI:L/VA:L/SC:N/SI:N/SA:N/E:P/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X
Description

A vulnerability was identified in CTCMS Content Management System up to 2.1.2. The affected element is the function Save of the file /ctcms/libs/Ct_App.php of the component Backend App Configuration Module. The manipulation of the argument CT_App_Paytype leads to code injection. Remote exploitation of the attack is possible. The exploit is publicly available and might be used.

Risk Information
cvss2
Base: 5.8
Severity: LOW
AV:N/AC:L/Au:M/C:P/I:P/A:P
cvss3
Base: 4.7
Severity: LOW
CVSS:3.1/AV:N/AC:L/PR:H/UI:N/S:U/C:L/I:L/A:L
cvss4
Base: 5.1
Severity: LOW
CVSS:4.0/AV:N/AC:L/AT:N/PR:H/UI:N/VC:L/VI:L/VA:L/SC:N/SI:N/SA:N/E:P/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X
Description

Weblate is a web based localization tool. In versions prior to 5.15, it was possible to accept an invitation opened by a different user. Version 5.15. contains a patch. As a workaround, avoid leaving one's Weblate sessions with an invitation opened unattended.

Risk Information
cvss4
Base: 1.0
Severity: HIGH
CVSS:4.0/AV:L/AC:H/AT:P/PR:L/UI:P/VC:L/VI:L/VA:N/SC:N/SI:N/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X